Chapter 6 – Nanotechnology safety in the biomedical industry

dc.contributor.authorBlatchley, Charles C.
dc.date.accessioned2013-07-01T20:10:33Z
dc.date.available2013-07-01T20:10:33Z
dc.date.issued2013
dc.descriptionClick on the DOI link to access this book chapter (may not be free)en_US
dc.description.abstractNanomaterials are of interest in many biomedical applications for potential enhancements in structural strength of bone implants, controlled drug release, improved chemical interactions, and scaffolding for cell in-growth and tissue replacement. Unfortunately, the key changes in material properties that enhance performance seem to lead in some cases to increased toxicity. By shifting the distribution of wear particle sizes to smaller individual particles, adverse effects may be created, either directly from the nanoparticle interactions or through intermediary species, such as reactive oxygen. Either way, biological activity often seems to be dependent on particle size, and deleterious side effects and workplace hazards must be evaluated and avoided.en_US
dc.identifier.citationCharles C. Blatchley, Chapter 6 - Nanotechnology Safety in the Biomedical Industry, In: R. Asmatulu, Editor(s), Nanotechnology Safety, Elsevier, Amsterdam, 2013, Pages 73-83, ISBN 9780444594389, http://dx.doi.org/10.1016/B978-0-444-59438-9.00006-0.en_US
dc.identifier.isbn9780444594389
dc.identifier.urihttp://dx.doi.org/10.1016/B978-0-444-59438-9.00006-0
dc.identifier.urihttp://hdl.handle.net/10057/5840
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesNanotechnology Safety;
dc.relation.ispartofseries;ch.6
dc.subjectImplant wearen_US
dc.subjectDrug releaseen_US
dc.subjectImagingen_US
dc.subjectDiagnosticsen_US
dc.subjectTissue scaffoldingen_US
dc.titleChapter 6 – Nanotechnology safety in the biomedical industryen_US
dc.typeBook chapteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: